DESIGN AND SYNTHESIS OF PRODRUGS OF ANTICANCER DRUGS FOR IMMUNOSPECIFIC ACTIVATION BY MONOCLONAL ANTIBODY-ENZYME CONJUGATES

被引：0
|
作者：
VRUDHULA, VM [1 ]
机构：
[1] BRISTOL MYERS SQUIBB,PHARMACEUT RES INST,SEATTLE,WA 98121
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1993年 / 206卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：32 / AGFD
相关论文
共 50 条
  • [21] ANTIBODY-ENZYME CONJUGATES CAN GENERATE CYTOTOXIC DRUGS FROM INACTIVE PRECURSORS AT TUMOR SITES
    BAGSHAWE, KD
    SHARMA, SK
    SPRINGER, CJ
    ANTONIW, P
    ROGERS, GT
    BURKE, PJ
    MELTON, R
    SHERWOOD, R
    ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS, 1991, 4 (04): : 915 - 922
  • [22] GALACTOSYLATED ANTIBODIES AND ANTIBODY-ENZYME CONJUGATES IN ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY
    SHARMA, SK
    BAGSHAWE, KD
    BURKE, PJ
    BODEN, JA
    ROGERS, GT
    SPRINGER, CJ
    MELTON, RG
    SHERWOOD, RF
    CANCER, 1994, 73 (03) : 1114 - 1120
  • [23] IN-VITRO ANTIBODY-ENZYME CONJUGATES WITH SPECIFIC BACTERICIDAL ACTIVITY
    KNOWLES, DM
    SULLIVAN, TJ
    PARKER, CW
    WILLIAMS, RC
    JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (06): : 1443 - 1452
  • [24] AFFINITY CYTOTOXICITY FOR TUMOR-CELLS WITH ANTIBODY-ENZYME CONJUGATES
    PHILPOTT, GW
    PARKER, CW
    BOWER, RJ
    JOURNAL OF CLINICAL INVESTIGATION, 1972, 51 (06): : A75 - &
  • [25] CEPHALOSPORIN DERIVATIVES OF DOXORUBICIN AS PRODRUGS FOR ACTIVATION BY MONOCLONAL ANTIBODY-BETA-LACTAMASE CONJUGATES
    VRUDHULA, VM
    SVENSSON, HP
    SENTER, PD
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (08) : 1380 - 1385
  • [26] SIMPLE METHOD FOR PREPARATION OF ANTIBODY-ENZYME CONJUGATES FOR ENZYME-LINKED IMMUNOSORBENT ASSAYS
    DEJONG, PJ
    JOURNAL OF CLINICAL MICROBIOLOGY, 1983, 17 (05) : 928 - 930
  • [27] Enzyme-catalyzed activation of anticancer prodrugs
    Rooseboom, M
    Commandeur, JNM
    Vermeulen, NPE
    PHARMACOLOGICAL REVIEWS, 2004, 56 (01) : 53 - 102
  • [28] Molecular Mechanisms of Antitumor Activity of PAMAM Dendrimer Conjugates with Anticancer Drugs and a Monoclonal Antibody
    Marcinkowska, Monika
    Stanczyk, Maciej
    Janaszewska, Anna
    Gajek, Arkadiusz
    Ksiezak, Malgorzata
    Dzialak, Paula
    Klajnert-Maculewicz, Barbara
    POLYMERS, 2019, 11 (09)
  • [29] Design of Anticancer Prodrugs for Reductive Activation
    Chen, Yu
    Hu, Longqin
    MEDICINAL RESEARCH REVIEWS, 2009, 29 (01) : 29 - 64
  • [30] SPECIFIC ACTIVATION OF GLUCURONIDE PRODRUGS BY ANTIBODY-TARGETED ENZYME CONJUGATES FOR CANCER-THERAPY
    WANG, SM
    CHERN, JW
    YEH, MY
    NG, YC
    TUNG, E
    ROFFLER, SR
    CANCER RESEARCH, 1992, 52 (16) : 4484 - 4491
12345